Page last updated: 2024-09-02

deguelin and Kaposi Sarcoma

deguelin has been researched along with Kaposi Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albini, A; Ambrosini, C; Dell'Eva, R; Ferrari, N; Minghelli, S; Noonan, DM	1

Other Studies

1 other study(ies) available for deguelin and Kaposi Sarcoma

Article	Year
The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway. Carcinogenesis, 2007, Volume: 28, Issue:2 Topics: Angiogenesis Inhibitors; Base Sequence; Cells, Cultured; DNA Primers; Enzyme-Linked Immunosorbent Assay; Homeostasis; Humans; NF-kappa B; Polymerase Chain Reaction; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Rotenone; Sarcoma, Kaposi; Tumor Suppressor Protein p53; Up-Regulation	2007

Article

Year

The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway.

Carcinogenesis, 2007, Volume: 28, Issue:2

Topics: Angiogenesis Inhibitors; Base Sequence; Cells, Cultured; DNA Primers; Enzyme-Linked Immunosorbent Assay; Homeostasis; Humans; NF-kappa B; Polymerase Chain Reaction; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Rotenone; Sarcoma, Kaposi; Tumor Suppressor Protein p53; Up-Regulation

2007